Notably, pDCs are the major producers of IFN-α in SLE, and IFN-α production from pDC mediated by TLR9 is reduced by mTOR inhibitor, which regulates pDC differentiation and activation by modulating mitochondrial biogenesis and energy metabolism (78). The gene discussed is TLR9; the disease is systemic lupus erythematosus.